Brief: Bellerophon Provides Clinical Program Update And Reports Second Quarter 2021 Financial Results
05/08/2021 15:34
Aug 5 (Reuters) - Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON PROVIDES CLINICAL PROGRAM UPDATE AND REPORTS
SECOND
QUARTER 2021 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.36
* AS OF JUNE 30, 2021, COMPANY HAD CASH AND CASH EQUIVALENTS
OF
$34.3 MILLION, COMPARED TO $47.6 MILLION AT DECEMBER 31, 2020
Source text for Eikon: ID:nGNX7V1Pnb
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen